BDBM312669 N-[1-[1-(3- acetamidopropyl)-4- piperidyl]-3-[5-chloro-2- (difluoromethoxy)phenyl] pyrazol-4-yl]-2-amino- pyrazolo[1,5- a]pyrimidine-3- carboxamide::US9604984, Example 150

SMILES COc1cccc(C[C@@H]2COc3ccc4ncc(F)cc4c3C(=O)N[C@H](C(=O)NCCn3nnc(C4CC4)n3)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@H](Cc3nc(C(F)(F)F)no3)C(=O)N2)n1

InChI Key InChIKey=OWEZXPGJBKGANV-UHFFFAOYSA-N

Data  2 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 312669   

TargetCytochrome P450 3A4(Human)
Idorsia Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 312669BDBM312669(US20260098060, Example 26)
Affinity DataIC50: 2.20E+3nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2026
Entry Details
US Patent